| |
| |
Briefing Papers
- Disclosure of origin of 'genetic resources'
September 2005
The Convention on Biological Diversity (CBD) seeks to promote: conservation of biological diversity; sustainable use of its components; equitable sharing of the benefits from the use of genetic resources.
- Intellectual Property protection for new plants
April 2009
Modern agriculture requires improvements in the technology of plant breeding to produce new varieties of plant which yield crops having improved resistance to diseases, pests, and other stresses...
- Patentability of stem cells in Europe
July 2009
Stem cell research is giving scientists the power to create new tools which might one day be used to repair or replace tissues, for example, to repair spinal cord injuries, to treat diabetes, Parkinson's disease, osteoporosis and heart attacks.
- Patenting in the pharmaceutical industry - supplementary protection certificates
October 2009
The Chartered Institute of Patent Agents strongly supports an all-industry approach to patenting inventions, including inventions made in the pharmaceutical industry...
- Patentability of animals
April 2008
Industrially useful inventions are generally patentable if they are novel and involve an inventive step (i.e. they are surprisingly different, rather than simply a development, modification or combination of previously known features)...
- Patenting of human gene sequences
June 2006
The technology known as "genetic engineering" involves the transfer of genetic information from one organism to another so that the modified organism can carry out the function for which the transferred genetic information provides the instructions...
- The United Nations Bio-Diversity Convention
February 2009
The United Nations Convention on Biological Diversity, known as the Biodiversity Convention or CBD, was enacted in Rio de Janeiro in June 1992. The Convention was originally signed by 157 governments. It came into force in December 1993...
|
|
|
|
